Imiquimod
02.12
Phase 3 small_molecule completed
Quick answer
Imiquimod for Lentigo Maligna is a Phase 3 program (small_molecule) at Elan Pharma International with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Elan Pharma International
- Indication
- Lentigo Maligna
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed